You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Breath diagnostics firm Owlstone Medical today announced GSK will use its Breath Biopsy platform in a clinical development program evaluating the efficacy of a chronic obstructive pulmonary disease drug candidate.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.